George W. Booz

8.0k total citations · 1 hit paper
148 papers, 6.1k citations indexed

About

George W. Booz is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, George W. Booz has authored 148 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Cardiology and Cardiovascular Medicine, 60 papers in Molecular Biology and 32 papers in Oncology. Recurrent topics in George W. Booz's work include Cytokine Signaling Pathways and Interactions (25 papers), Renin-Angiotensin System Studies (20 papers) and Receptor Mechanisms and Signaling (17 papers). George W. Booz is often cited by papers focused on Cytokine Signaling Pathways and Interactions (25 papers), Renin-Angiotensin System Studies (20 papers) and Receptor Mechanisms and Signaling (17 papers). George W. Booz collaborates with scholars based in United States, Lebanon and France. George W. Booz's co-authors include Kenneth M. Baker, Mazen Kurdi, David E. Dostal, Fouad A. Zouein, Fan Fan, Raffaele Altara, Richard J. Roman, Thomas M. Coffman, Steven J. Forrester and Rosario Scalia and has published in prestigious journals such as Journal of Biological Chemistry, Physiological Reviews and PLoS ONE.

In The Last Decade

George W. Booz

136 papers receiving 6.0k citations

Hit Papers

Angiotensin II Signal Transduction: An Update on Mechanis... 2018 2026 2020 2023 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George W. Booz United States 41 2.6k 2.5k 878 705 700 148 6.1k
Óscar Lorenzo Spain 42 2.3k 0.9× 2.4k 0.9× 1.2k 1.3× 491 0.7× 798 1.1× 110 6.3k
Shokei Kim Japan 44 2.6k 1.0× 2.6k 1.0× 1.1k 1.2× 388 0.6× 708 1.0× 119 5.9k
Masaki Mogi Japan 43 2.1k 0.8× 1.9k 0.8× 1.3k 1.4× 322 0.5× 420 0.6× 179 5.4k
Shokei Kim‐Mitsuyama Japan 41 1.5k 0.6× 1.7k 0.7× 1.3k 1.5× 546 0.8× 962 1.4× 116 5.7k
Pierre Paradis Canada 40 2.3k 0.9× 1.8k 0.7× 1.2k 1.4× 273 0.4× 817 1.2× 109 5.4k
Sven Waßmann Germany 39 2.5k 0.9× 2.0k 0.8× 1.3k 1.4× 468 0.7× 890 1.3× 101 7.0k
Hiroshi Iwao Japan 48 3.2k 1.2× 3.7k 1.5× 1.2k 1.4× 619 0.9× 917 1.3× 249 8.2k
Hyung‐Suk Kim United States 39 2.2k 0.8× 2.1k 0.8× 1.5k 1.7× 242 0.3× 465 0.7× 95 5.4k
Pingjin Gao China 40 1.7k 0.6× 1.6k 0.7× 758 0.9× 235 0.3× 678 1.0× 213 5.1k
Taixing Cui United States 50 1.6k 0.6× 4.0k 1.6× 755 0.9× 349 0.5× 575 0.8× 114 7.1k

Countries citing papers authored by George W. Booz

Since Specialization
Citations

This map shows the geographic impact of George W. Booz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George W. Booz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George W. Booz more than expected).

Fields of papers citing papers by George W. Booz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George W. Booz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George W. Booz. The network helps show where George W. Booz may publish in the future.

Co-authorship network of co-authors of George W. Booz

This figure shows the co-authorship network connecting the top 25 collaborators of George W. Booz. A scholar is included among the top collaborators of George W. Booz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George W. Booz. George W. Booz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biondi‐Zoccai, Giuseppe, Giacomo Frati, Roberto Carnevale, & George W. Booz. (2025). Human-Based Technologies in Cardiovascular Pharmacology Research. Journal of Cardiovascular Pharmacology. 86(5). 413–419.
2.
Vitali, Andrea, Fouad A. Zouein, George W. Booz, & Raffaele Altara. (2025). Clinical utility of myocardial work assessment in arterial hypertension and cardiovascular diseases. Minerva Cardiology and Angiology. 73(4). 400–409.
3.
Kaplan, Abdullah, et al.. (2025). Canonical or non‐canonical, all aspects of G protein‐coupled receptor kinase 2 in heart failure. Acta Physiologica. 241(3). e70010–e70010. 1 indexed citations
5.
Mericskay, Mathias, et al.. (2024). Potential Alternative Receptors for SARS-CoV-2-Induced Kidney Damage: TLR-4, KIM-1/TIM-1, and CD147. Frontiers in Bioscience-Landmark. 29(1). 8–8. 3 indexed citations
6.
Jones, Kylie, et al.. (2024). Intrauterine growth‐restricted pregnant rats, from placental ischemic dams, display preeclamptic‐like symptoms: A new rat model of preeclampsia. Physiological Reports. 12(21). e70112–e70112. 3 indexed citations
7.
Kaplan, Abdullah, et al.. (2024). Estrogen administration enhances the adverse effects of cigarette smoking on the heart in cycling female mice. Biology of Sex Differences. 15(1). 100–100.
8.
Khabsa, Joanne, et al.. (2023). Risk of thromboembolic events in non-hospitalized COVID-19 patients: A systematic review. European Journal of Pharmacology. 941. 175501–175501. 6 indexed citations
10.
Kaplan, Abdullah, et al.. (2023). Cooling Down Inflammation in the Cardiovascular System via the Nicotinic Acetylcholine Receptor. Journal of Cardiovascular Pharmacology. 82(4). 241–265. 2 indexed citations
11.
Tannous, Cynthia, Rana Ghali, George W. Booz, et al.. (2023). Nicotinamide Riboside Supplementation Restores Myocardial Nicotinamide Adenine Dinucleotide Levels, Improves Survival, and Promotes Protective Environment Post Myocardial Infarction. Cardiovascular Drugs and Therapy. 38(6). 1385–1396. 10 indexed citations
12.
Ghali, Rana, Ali Mroueh, Abdullah Kaplan, et al.. (2022). Sexual dimorphism in acute myocardial infarction-induced acute kidney injury: cardiorenal deteriorating effects of ovariectomy in premenopausal female mice. Clinical Science. 137(1). 47–63. 3 indexed citations
13.
Kaplan, Abdullah, et al.. (2022). Sex differences in cardiac remodeling post myocardial infarction with acute cigarette smoking. Biology of Sex Differences. 13(1). 36–36. 9 indexed citations
14.
Kaplan, Abdullah, Raffaele Altara, Marco Manca, et al.. (2021). Distorted assessment of left atrial size by echocardiography in patients with increased aortic root diameter. The Egyptian Heart Journal. 73(1). 55–55.
15.
16.
Pillot, Bruno, Lionel Augeul, M. Paillard, et al.. (2019). Critical appraisal of STAT3 pattern in adult cardiomyocytes. Journal of Molecular and Cellular Cardiology. 131. 91–100. 11 indexed citations
17.
Kaplan, Abdullah, et al.. (2017). Functional, Cellular, and Molecular Remodeling of the Heart under Influence of Oxidative Cigarette Tobacco Smoke. Oxidative Medicine and Cellular Longevity. 2017(1). 3759186–3759186. 40 indexed citations
18.
Zeng, Heng, Venkata Ramana Vaka, Xiaochen He, George W. Booz, & Jian‐Xiong Chen. (2015). High‐fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss. Journal of Cellular and Molecular Medicine. 19(8). 1847–1856. 104 indexed citations
19.
Zgheib, Carlos, Fouad A. Zouein, Rony Chidiac, Mazen Kurdi, & George W. Booz. (2011). Calyculin A Reveals Serine/Threonine Phosphatase Protein Phosphatase 1 as a Regulatory Nodal Point in Canonical Signal Transducer and Activator of Transcription 3 Signaling of Human Microvascular Endothelial Cells. Journal of Interferon & Cytokine Research. 32(2). 87–94. 12 indexed citations
20.
Kurdi, Mazen & George W. Booz. (2007). Jak Inhibition, but Not Stat1 Knockdown, Blocks the Synergistic Effect of IFN-γ on Fas-Induced Apoptosis of A549 Human Non-Small Cell Lung Cancer Cells. Journal of Interferon & Cytokine Research. 27(1). 23–31. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026